P3.18.42 Camrelizumab Combined With Chemotherapy and Local Consolidative Therapy for Untreated Oligometastatic NSCLC With PD-L1 Expression <50%
Year: 2025
Type: article
Source: Journal of Thoracic Oncology
Authors: L.P. Lin, H.J. Bao, X. Luo, J.F. Guo, P.F. Chen, C.J. Deng, H.R. Su, F.X. Huang, X.L. Cao, J.Z. Hu
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4415519206
